CAV1 and breast carcinoma: Therefore, we then tested whether the autophagy contributed to the Doxo resistance in CAV1-deficient breast cancer cell by using an autophagy inhibitor, HCQ (the only clinically approved autophagy inhibitor) and knock down of an essential gene for autophagy, ATG7.70